PACLITAXEL, LIBTAYO 350 mg concentrate for solution for infusion., CARBOPLATIN
IFCT-2401 SPORADIC
Phase 2 small_molecule active
Quick answer
PACLITAXEL, LIBTAYO 350 mg concentrate for solution for infusion., CARBOPLATIN for Unresectable stage III Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Unresectable stage III Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active